ArticleScientific reports2026
Exploratory study on blood and urine transcriptomes for identifying miRNA biomarkers in pediatric febrile bacterial and viral infections.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Modern clinical practice lacks rapid, reliable, and non-invasive methods to distinguish between bacterial and viral infections. It negatively impacts the effectiveness of treatment and increases the risk of unnecessary antibiotic administration and thus antibiotic resistance spread. Using microRNA (miRNA) biomarkers in urine may become the solution to the problems listed. miRNAs in urine are relatively stable and can provide an indirect yet specific insight into systemic infections, offering a promising diagnostic tool. In this pilot study, urine small RNA and blood full transcriptome sequencing data were analyzed in children with bacterial infections (n = 7), viral infections (n = 7), and controls (n = 8). The objectives were to identify exploratory urinary miRNA signatures and attempt to indirectly correlate differentially expressed (DE) urinary miRNAs with DE transcripts in blood. Using LASSO regularized logistic regression and ANOVA, miRNA biomarker candidates were prioritized. Cross-compartment miRNA: mRNA interactions were putatively evaluated using correlation analysis and target prediction. LASSO regularized regression identified a 5-miRNA signature yielding an apparent internal AUC score of 0.981, though wide confidence intervals reflect the exploratory nature of this small cohort. The prioritized miRNAs demonstrated a descriptive capacity to cluster the patient groups. Correlation analysis and target prediction highlighted parallel molecular patterns across biological fluids, mapping to key immune processes such as cytokine-cytokine receptor interactions and T-cell activation. Our pilot study suggests that prioritized urine miRNA biomarkers reflect host infectious etiology and merit further investigation. While internal performance metrics require validation in larger, independent cohorts, the non-invasive approach represents a promising step toward targeted, timely treatment and the reduction of antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.